Long non-coding RNAs: Functional regulatory players in breast cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int. J. Canc., 136, E359, 10.1002/ijc.29210
Yousef, 2017, MCM2: an alternative to Ki-67 for measuring breast cancer cell proliferation, Mod. Pathol., 30, 682, 10.1038/modpathol.2016.231
Turashvili, 2017, Tumor heterogeneity in breast cancer, Front. Med., 4, 227, 10.3389/fmed.2017.00227
Livasy, 2006, Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma, Mod. Pathol., 19, 264, 10.1038/modpathol.3800528
Youness, 2018, A novel role of sONE/NOS3/NO signaling cascade in mediating hydrogen sulphide bilateral effects on triple negative breast cancer progression, Nitric Oxide, 80, 12, 10.1016/j.niox.2018.07.004
Blows, 2010, Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies, PLoS Med., 7, e1000279, 10.1371/journal.pmed.1000279
Lin, 2009, Triple negative breast carcinoma is a prognostic factor in Taiwanese women, BMC Canc., 9, 192, 10.1186/1471-2407-9-192
Rivenbark, 2013, Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine, Am. J. Pathol., 183, 1113, 10.1016/j.ajpath.2013.08.002
Bianchini, 2016, Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease, Nat. Rev. Clin. Oncol., 13, 674, 10.1038/nrclinonc.2016.66
Yamauchi, 2009, Molecular targets for treatment of inflammatory breast cancer, Nat. Rev. Clin. Oncol., 6, 387, 10.1038/nrclinonc.2009.73
O'Reilly, 2006, mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt, Cancer Res., 66, 1500, 10.1158/0008-5472.CAN-05-2925
Zitzmann, 2010, Compensatory activation of Akt in response to mTOR and Raf inhibitors - a rationale for dual-targeted therapy approaches in neuroendocrine tumor disease, Cancer Lett., 295, 100, 10.1016/j.canlet.2010.02.018
Youness, 2016, MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc, Oncol Lett, 12, 2567, 10.3892/ol.2016.4914
Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5
Morceau, 2013, Long and short non-coding RNAs as regulators of hematopoietic differentiation, Int. J. Mol. Sci., 14, 14744, 10.3390/ijms140714744
Zhou, 2018, Prospects of noncoding RNAs in hepatocellular carcinoma, BioMed Res. Int., 2018, 6579436, 10.1155/2018/6579436
Ojha, 2019, Emerging role of circulating microRNA in the diagnosis of human infectious diseases, J. Cell. Physiol., 234, 1030, 10.1002/jcp.27127
Gulia, 2017, Role of non-coding RNAs in the etiology of bladder cancer, Genes, 8, 10.3390/genes8110339
Shaalan, 2018, Destabilizing the interplay between miR-1275 and IGF2BPs by Tamarix articulata and quercetin in hepatocellular carcinoma, Nat. Prod. Res., 32, 2217, 10.1080/14786419.2017.1366478
Rahmoon, 2017, MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R in hepatocellular carcinoma patients, Growth Factors, 35, 76, 10.1080/08977194.2017.1354859
Youness, 2016, Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression, Growth Factors, 34, 128, 10.1080/08977194.2016.1200571
Kung, 2013, Long noncoding RNAs: past, present, and future, Genetics, 193, 651, 10.1534/genetics.112.146704
Shen, 1991, NADPH-cytochrome P-450 oxidoreductase. The role of cysteine 566 in catalysis and cofactor binding, J. Biol. Chem., 266, 19976, 10.1016/S0021-9258(18)54879-1
Clark, 2015, Quantitative gene profiling of long noncoding RNAs with targeted RNA sequencing, Nat. Methods, 12, 339, 10.1038/nmeth.3321
Guttman, 2009, Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals, Nature, 458, 223, 10.1038/nature07672
Jalali, 2016, Navigating the dynamic landscape of long noncoding RNA and protein-coding gene annotations in GENCODE, Hum. Genom., 10, 35, 10.1186/s40246-016-0090-2
Quinn, 2016, Unique features of long non-coding RNA biogenesis and function, Nat. Rev. Genet., 17, 47, 10.1038/nrg.2015.10
Qi, 2013, The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine, Mod. Pathol., 26, 155, 10.1038/modpathol.2012.160
de Oliveira, 2018, LncRNAs in Cancer: another layer of complexity, J. Gene Med., e3065, 10.1002/jgm.3065
Ma, 2019, LINC01585 functions as a regulator of gene expression by the CAMP/CREB signaling pathway in breast cancer, Gene, 684, 139, 10.1016/j.gene.2018.10.063
Wang, 2018, Long noncoding RNA signature and disease outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen, J Breast Cancer, 21, 277, 10.4048/jbc.2018.21.e39
Campos-Parra, 2018, Long non-coding RNAs as new master regulators of resistance to systemic treatments in breast cancer, Int. J. Mol. Sci., 19, 10.3390/ijms19092711
Abbastabar, 2018, lncRNA involvement in hepatocellular carcinoma metastasis and prognosis, EXCLI J, 17, 900
Warden, 2008, Predicted functional RNAs within coding regions constrain evolutionary rates of yeast proteins, PLoS One, 3, e1559, 10.1371/journal.pone.0001559
Cabili, 2011, Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses, Genes Dev., 25, 1915, 10.1101/gad.17446611
Derrien, 2012, The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression, Genome Res., 22, 1775, 10.1101/gr.132159.111
Morris, 2009, Long antisense non-coding RNAs function to direct epigenetic complexes that regulate transcription in human cells, Epigenetics, 4, 296, 10.4161/epi.4.5.9282
Kapranov, 2007, RNA maps reveal new RNA classes and a possible function for pervasive transcription, Science, 316, 1484, 10.1126/science.1138341
Nie, 2012, Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer, Am J Transl Res, 4, 127
Kino, 2010, Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor, Sci. Signal., 3, ra8, 10.1126/scisignal.2000568
Klinge, 2018, Non-coding RNAs in breast cancer: intracellular and intercellular communication, Noncoding RNA, 4
Wang, 2017, Long noncoding RNAs (lncRNAs) in triple negative breast cancer, J. Cell. Physiol., 232, 3226, 10.1002/jcp.25830
Xu, 2017, Oncogenic long noncoding RNA landscape in breast cancer, Mol. Canc., 16, 129, 10.1186/s12943-017-0696-6
Huang, 2017, Uncovering the roles of long non-coding RNAs in cancer stem cells, J. Hematol. Oncol., 10, 62, 10.1186/s13045-017-0428-9
Su, 2015, Circulating long noncoding RNA as a potential target for prostate cancer, Int. J. Mol. Sci., 16, 13322, 10.3390/ijms160613322
Hansji, 2014, Keeping abreast with long non-coding RNAs in mammary gland development and breast cancer, Front. Genet., 5, 379, 10.3389/fgene.2014.00379
Lv, 2016, LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer, Oncotarget, 7, 13047, 10.18632/oncotarget.7509
Rinn, 2007, Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs, Cell, 129, 1311, 10.1016/j.cell.2007.05.022
Geng, 2011, Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression, J. Int. Med. Res., 39, 2119, 10.1177/147323001103900608
Kim, 2013, HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer, Oncogene, 32, 1616, 10.1038/onc.2012.193
Nakagawa, 2013, Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer, Biochem. Biophys. Res. Commun., 436, 319, 10.1016/j.bbrc.2013.05.101
Hu, 2018, Knock down lncRNA HOTAIR sensitize breast cancer cells to ionizing radiation through activating miR-218, Biosci. Rep., 10.1042/BSR20181038
Gupta, 2010, Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis, Nature, 464, 1071, 10.1038/nature08975
Tao, 2015, Estradiol induces HOTAIR levels via GPER-mediated miR-148a inhibition in breast cancer, J. Transl. Med., 13, 131, 10.1186/s12967-015-0489-x
Yang, 2016, Delphinidin-3-glucoside suppresses breast carcinogenesis by inactivating the Akt/HOTAIR signaling pathway, BMC Canc., 16, 423, 10.1186/s12885-016-2465-0
Wang, 2015, Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR, Oncotarget, 6, 11150, 10.18632/oncotarget.3441
Wu, 2018, Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53, Eur. Rev. Med. Pharmacol. Sci., 22, 4467
Wang, 2018, LINP1 facilitates DNA damage repair through non-homologous end joining (NHEJ) pathway and subsequently decreases the sensitivity of cervical cancer cells to ionizing radiation, Cell Cycle, 17, 439, 10.1080/15384101.2018.1442625
Liu, 2018, Increased long noncoding RNA LINP1 expression and its prognostic significance in human breast cancer, Eur. Rev. Med. Pharmacol. Sci., 22, 8749
Liang, 2018, Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer, Cancer Biol. Ther., 19, 120, 10.1080/15384047.2017.1394543
Zlotorynski, 2016, Non-coding RNA: LINP1 joins ends with triple-negative effect, Nat. Rev. Mol. Cell Biol., 17, 330, 10.1038/nrm.2016.60
Li, 2018, LncRNA MALAT1 promotes relapse of breast cancer patients with postoperative fever, Am J Transl Res, 10, 3186
Huang, 2018, MALAT1 promotes angiogenesis of breast cancer, Oncol. Rep., 40, 2683
Arshi, 2018, Expression analysis of MALAT1, GAS5, SRA, and NEAT1 lncRNAs in breast cancer tissues from young women and women over 45 Years of age, Mol. Ther. Nucleic Acids, 12, 751, 10.1016/j.omtn.2018.07.014
Zhao, 2018, The functional pathway analysis and clinical significance of miR-20a and its related lncRNAs in breast cancer, Cell. Signal., 51, 152, 10.1016/j.cellsig.2018.08.004
Gutschner, 2013, The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells, Cancer Res., 73, 1180, 10.1158/0008-5472.CAN-12-2850
Bernard, 2010, A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression, EMBO J., 29, 3082, 10.1038/emboj.2010.199
Dong, 2015, MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway, Tumour Biol, 36, 1477, 10.1007/s13277-014-2631-4
Wang, 2015, Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells, J. Biol. Chem., 290, 3925, 10.1074/jbc.M114.596866
Jin, 2016, Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development, Tumour Biol, 37, 7383, 10.1007/s13277-015-4605-6
Jadaliha, 2016, Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer, Oncotarget, 7, 40418, 10.18632/oncotarget.9622
Mendell, 2016, Targeting a long noncoding RNA in breast cancer, N. Engl. J. Med., 374, 2287, 10.1056/NEJMcibr1603785
Xiping, 2018, Roles of MALAT1 in development and migration of triple negative and Her-2 positive breast cancer, Oncotarget, 9, 2255, 10.18632/oncotarget.23370
Panzitt, 2007, Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA, Gastroenterology, 132, 330, 10.1053/j.gastro.2006.08.026
Matouk, 2009, Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis, Eur. J. Gastroenterol. Hepatol., 21, 688, 10.1097/MEG.0b013e328306a3a2
Dong, 2019, Long non-coding RNA HULC interacts with miR-613 to regulate colon cancer growth and metastasis through targeting RTKN, Biomed. Pharmacother., 109, 2035, 10.1016/j.biopha.2018.08.017
Su, 2018, [Effect of long non-coding RNA highly upregulated in liver cancer on the biological behavior of oral squamous cell carcinoma], Zhonghua Kou Qiang Yi Xue Za Zhi, 53, 760
Xian, 2018, Circulating long non-coding RNAs HULC and ZNFX1-AS1 are potential biomarkers in patients with gastric cancer, Oncol Lett, 16, 4689
Shi, 2016, Long noncoding RNA highly up-regulated in liver cancer predicts unfavorable outcome and regulates metastasis by MMPs in triple-negative breast cancer, Arch. Med. Res., 47, 446, 10.1016/j.arcmed.2016.11.001
Wang, 2010, CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer, Nucleic Acids Res., 38, 5366, 10.1093/nar/gkq285
Wang, 2017, The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186, J. Biol. Chem., 292, 15395, 10.1074/jbc.M117.783738
Sang, 2016, LncRNA PANDAR regulates the G1/S transition of breast cancer cells by suppressing p16(INK4A) expression, Sci. Rep., 6, 22366, 10.1038/srep22366
Hung, 2011, Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters, Nat. Genet., 43, 621, 10.1038/ng.848
Yang, 2018, Overexpression of lncRNA PANDAR predicts adverse prognosis in acute myeloid leukemia, Cancer Manag. Res., 10, 4999, 10.2147/CMAR.S180150
Li, 2017, PANDAR: a pivotal cancer-related long non-coding RNA in human cancers, Mol. Biosyst., 13, 2195, 10.1039/C7MB00414A
Li, 2017, Knockdown of lncRNA-PANDAR suppresses the proliferation, cell cycle and promotes apoptosis in thyroid cancer cells, EXCLI J, 16, 354
Loewer, 2010, Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells, Nat. Genet., 42, 1113, 10.1038/ng.710
Takahashi, 2014, Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer, FEBS Open Bio, 4, 458, 10.1016/j.fob.2014.04.007
Zhou, 2014, Linc-RNA-RoR acts as a "sponge" against mediation of the differentiation of endometrial cancer stem cells by microRNA-145, Gynecol. Oncol., 133, 333, 10.1016/j.ygyno.2014.02.033
Zhan, 2016, LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway, Cancer Lett., 374, 261, 10.1016/j.canlet.2016.02.018
Lu, 2019, Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway, J. Cell. Physiol., 234, 1904, 10.1002/jcp.27066
Eades, 2015, lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6, Mol. Canc. Res., 13, 330, 10.1158/1541-7786.MCR-14-0251
Hou, 2014, LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis, Cell Death Dis., 5, e1287, 10.1038/cddis.2014.249
Shang, 2018, LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1, OncoTargets Ther., 11, 639, 10.2147/OTT.S157638
Takahashi, 2014, Modulation of hypoxia-signaling pathways by extracellular linc-RoR, J. Cell Sci., 127, 1585, 10.1242/jcs.141069
Zhang, 2013, The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage, Cell Res., 23, 340, 10.1038/cr.2012.164
Gao, 2016, ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer, Oncotarget, 7, 1608, 10.18632/oncotarget.6450
Chen, 2016, Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells, Tumour Biol, 37, 10861, 10.1007/s13277-016-4909-1
Hou, 2018, Long noncoding RNA ROR promotes breast cancer by regulating the TGF-beta pathway, Cancer Cell Int., 18, 142, 10.1186/s12935-018-0638-4
Lu, 2013, Downregulation of gas5 increases pancreatic cancer cell proliferation by regulating CDK6, Cell Tissue Res., 354, 891, 10.1007/s00441-013-1711-x
Yin, 2014, Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer, Med. Oncol., 31, 253, 10.1007/s12032-014-0253-8
Dong, 2015, The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression, J. Hematol. Oncol., 8, 43, 10.1186/s13045-015-0140-6
Tu, 2014, Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma, Int. J. Clin. Exp. Pathol., 7, 4303
Zong, 2019, miR-221/222 promote tumor growth and suppress apoptosis by targeting lncRNA GAS5 in breast cancer, Biosci. Rep., 39, 10.1042/BSR20181859
Gu, 2018, Effect of the LncRNA GAS5-MiR-23a-ATG3 Axis in regulating autophagy in patients with breast cancer, Cell. Physiol. Biochem., 48, 194, 10.1159/000491718
Li, 2018, Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p, Biomed. Pharmacother., 104, 451, 10.1016/j.biopha.2018.05.056
Gu, 2018, Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer, Cancer Lett., 434, 1, 10.1016/j.canlet.2018.06.039
Esmatabadi, 2018, Down-regulation of lncRNA, GAS5 decreases chemotherapeutic effect of dendrosomal curcumin (DNC) in breast cancer cells, Phytomedicine, 42, 56, 10.1016/j.phymed.2018.03.022
Mourtada-Maarabouni, 2009, GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer, Oncogene, 28, 195, 10.1038/onc.2008.373
Pickard, 2014, Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy, Breast Canc. Res. Treat., 145, 359, 10.1007/s10549-014-2974-y
Lei, 2018, LncRNA NBAT-1 is down-regulated in lung cancer and influences cell proliferation, apoptosis and cell cycle, Eur. Rev. Med. Pharmacol. Sci., 22, 1958
Yan, 2017, Long noncoding RNA NBAT-1 suppresses tumorigenesis and predicts favorable prognosis in ovarian cancer, OncoTargets Ther., 10, 1993, 10.2147/OTT.S124645
Xue, 2015, Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma, Int. J. Clin. Exp. Pathol., 8, 3765
Hu, 2015, NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2, Oncotarget, 6, 32410, 10.18632/oncotarget.5609
Wu, 2019, LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis, J. Cell Mol. Med., 23, 29, 10.1111/jcmm.13658
Zhang, 2018, Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21, Eur. Rev. Med. Pharmacol. Sci., 22, 8315
Zhang, 2018, Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-kappaB and p53, J. Cell. Biochem., 10.1002/jcb.27982
Binabaj, 2018, The prognostic value of long noncoding RNA MEG3 expression in the survival of patients with cancer: a meta-analysis, J. Cell. Biochem., 119, 9583, 10.1002/jcb.27276
Zhou, 2018, LncRNA-MIAT regulates fibrosis in hypertrophic cardiomyopathy (HCM) by mediating the expression of miR-29a-3p, J. Cell. Biochem., 10.1002/jcb.28001
Zhu, 2018, MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway, Arch. Biochem. Biophys., 661, 22, 10.1016/j.abb.2018.10.021
Gnant, 2011, St. Gallen 2011: summary of the consensus discussion, Breast Care, 6, 136, 10.1159/000328054
Ahn, 2015, Differences in clinical outcomes between luminal A and B type breast cancers according to the st. Gallen consensus 2013, J Breast Cancer, 18, 149, 10.4048/jbc.2015.18.2.149
Nounou, 2015, Breast cancer: conventional diagnosis and treatment modalities and recent patents and technologies, Breast Canc., 9, 17